Mohammad M. Chisti
Expertise in
79
conditions

Dr. Mohammad M. Chisti

Hematology | Oncology
44199 Dequindre Road, Suite G-10, 
Troy, MI 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
79
conditions
44199 Dequindre Road, Suite G-10, 
Troy, MI 

Overview

Mohammad Chisti is a Hematologist and an Oncologist practicing medicine in Troy, Michigan.

Dr. Chisti is highly rated in 79 conditions, according to our data. His clinical expertise encompasses Follicular Lymphoma, Chronic Myelogenous Leukemia (CML), Anemia, Bone Marrow Aspiration, and Gastrostomy.

Dr. Chisti is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 22 peer reviewed articles and participating in 4 clinical trials. Dr. Chisti is currently accepting new patients.

Specialties

Hematology
Oncology

Licenses

General Acute Care Hospital in MI

Board Certifications

American Board Of Internal Medicine

Fellowships

Beaumont Hospital

Hospital Affiliations

Corewell Health Farmington Hills Hospital
Corewell Health William Beaumont University Hospital
Corewell Health Beaumont Troy Hospital
Beaumont Hospital - Farmington Hills
Beaumont Hospital - Dearborn
Beaumont Hospital, Troy
Beaumont Hospital - Grosse Pointe
Beaumont Hospital Royal Oak

Languages Spoken

English
Hindi
Kashmiri
Urdu

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Longevity Health Plan
  • MEDICARE SNP
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 19 Less Insurance Carriers -

Locations

Corewell Health Beaumont Troy Hospital Hematology & Oncology - 44199 Dequindre Rd
44199 Dequindre Road, Suite G-10, Troy, MI 48085
Other Locations
Corewell Health William Beaumont University Hospital Hematology & Oncology - 3577 W 13 Mile Rd
3577 West 13 Mile Road, Suite 101, Royal Oak, MI 48073

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Prospective Observational Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Prospective Observational Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Enrollment Status: Recruiting
Publish Date: October 08, 2025
Intervention Type: Other, Drug
Study Drug: Carvedilol
Study Phase: Phase 3
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 02, 2026
Intervention Type: Other
Study Phase: Phase 3
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
A Randomized, Open-Label, Phase 3 Study of Abemaciclib Combined With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone in Patients With High Risk, Node Positive, Early Stage, Hormone Receptor Positive, Human Epidermal Receptor 2 Negative, Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 24, 2026
Intervention Type: Drug
Study Drugs: Abemaciclib, Standard Adjuvant Endocrine Therapy
Study Phase: Phase 3
Study of the Effects of Dexamethasone on Non-Small Cell Lung Cancer Using [F-18] FLT for Imaging With Positron Emission Tomography (PET)
Study of the Effects of Dexamethasone on Non-Small Cell Lung Cancer Using [F-18] FLT for Imaging With Positron Emission Tomography (PET)
Enrollment Status: Completed
Publish Date: August 22, 2025
Intervention Type: Procedure, Device, Other, Drug
Study Phase: Not Applicable
View 3 Less Clinical Trials

22 Total Publications

Targeted Therapy in Erdheim-Chester Disease: A Case Report and Review of the Literature.
Targeted Therapy in Erdheim-Chester Disease: A Case Report and Review of the Literature.
Journal: Cureus
Published: May 22, 2026
Similar Doctors
Expertise in
32
conditions
Dr. Rashmi K. Chugh
Oncology | Hematology
Expertise in
32
conditions
Dr. Rashmi K. Chugh
Oncology | Hematology
Referral may be required

Rogel Cancer Center

1500 E Medical Center Dr, Floor B1 Reception E, 
Ann Arbor, MI 
 (39.8 miles away)
734-647-8902
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rashmi Chugh is an Oncologist and a Hematologist practicing medicine in Ann Arbor, Michigan. Dr. Chugh is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Epithelioid Sarcoma, Desmoid Tumor, and Ewing Sarcoma. Dr. Chugh is currently accepting new patients.

Expertise in
36
conditions
Dr. Rajen J. Mody
Hematology | Oncology
Expertise in
36
conditions
Dr. Rajen J. Mody
Hematology | Oncology
Referral may be required

University Of Michigan Medical Center

1500 E Medical Center Dr, 
Ann Arbor, MI 
 (39.8 miles away)
734-936-9814
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients

Rajen Mody is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Mody is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, Neuroepithelioma, and Bone Marrow Aspiration. Dr. Mody is currently accepting new patients.

Expertise in
8
conditions
Dr. Michael U. Callaghan
Hematology | Oncology
Expertise in
8
conditions
Dr. Michael U. Callaghan
Hematology | Oncology
Referral may be required

DMC Children's Hospital Of Michigan

3901 Beaubien St, 
Detroit, MI 
 (18.6 miles away)
313-745-5515
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Callaghan is a Hematologist and an Oncologist practicing medicine in Detroit, Michigan. Dr. Callaghan is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Hemophilia A, Blood Clots, Sickle Cell Disease, Evans Syndrome, and Splenectomy. Dr. Callaghan is currently accepting new patients.

Frequently Asked Questions about Dr. Mohammad M. Chisti

How do I make an appointment with Dr. Mohammad M. Chisti?

You can book an appointment with Dr. Mohammad M. Chisti by calling their office at 248-964-6111. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mohammad M. Chisti a top-rated expert for Follicular Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mohammad M. Chisti is classified as an Distinguished expert for Follicular Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mohammad M. Chisti specialize in?

While Dr. Mohammad M. Chisti is a Hematology, they have specific expertise in Follicular Lymphoma, Chronic Myelogenous Leukemia (CML), and Anemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Mohammad M. Chisti participate in research or clinical trials?

Yes. Dr. Mohammad M. Chisti has published 22 articles and abstracts on conditions like Follicular Lymphoma. You can view a list of Dr. Mohammad M. Chisti's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mohammad M. Chisti accept my insurance?

Dr. Mohammad M. Chisti accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 248-964-6111 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chisti's expertise for a condition
ConditionClose
    View All 20 Distinguished Conditions
    View All 59 Advanced Conditions
    View All 138 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile